Video

Dr. Richards on Urinary Tract Infections Associated With Worse Bladder Cancer Outcomes

Kyle A. Richards, MD, assistant professor, University of Wisconsin, discusses the association between urinary tract infections (UTI) and worse bladder cancer outcomes in the Medicare population.

Kyle A. Richards, MD, assistant professor, University of Wisconsin, discusses a retrospective analysis of the association between urinary tract infections (UTI) and worse outcomes in patients with bladder cancer from a Medicare database analysis.

A recent study used Surveillance, Epidemiology, and End Results (SEER) Medicare data to examine a cohort of patients with bladder cancer. Researchers analyzed the symptoms patients presented with and if it was a hematuria or UTI claim, as well as the time frame from symptom presentation to diagnosis.

Researchers then went forward to examine the outcomes of these patients and if they varied, based on time of diagnosis and presented symptoms, Richards explains.

Data showed that women who presented with a UTI claim had worse pathology and survival outcomes compared to women with hematuria. There was a similar association with men enrolled in the study; however, the association was greater in women.

<<<

View more from the 2015 AUA Annual Meeting

Related Videos
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Tiago Biachi, MD, PhD
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Benjamin P. Levy, MD, with Kristie Kahl and Andrew Svonavec
Alberto Montero, MD, MBA, CPHQ
Thomas Westbrook, MD, assistant professor, Rush University Medical Center